Deprecated!
This application is deprecated. Please use the latest version of the tool here.
Please cite:
I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni, G. Georgakilas, T. Vergoulis, I. Kanellos, I-L. Anastasopoulos, S. Maniou, K. Karathanou, D. Kalfakakou, A. Fevgas, T. Dalamagas and A. G. Hatzigeorgiou. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucl. Acids Res. (2014)
Data Download:
DIANA-TarBase v7 is available for scientific non-profit and non-commercial use! Download TarBase v7 by following this link
|
||||||||
Related Pathways
Publication year
Prediction score
Filters
Selected:
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Remove all 

Species

Method Type

Method

Regulation type

Validation type

Validated as

Source

Publication year
Prediction score
Loading...![]() |
Wait until the result set is completed... |
Gene name
miRNA name
Methods
Pred.Score
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:29700815-29700836 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:110294161-110294182 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:25209716-25209736 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:155913145-155913167 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:155913145-155913167 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:12722178-12722205 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:36602014-36602036 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:69022788-69022798 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:29626121-29626149 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:56394560-56394578 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:107808191-107808213 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:151807984-151808012 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:57410939-57410965 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:122848351-122848377 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:59662920-59662940 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:112116612-112116635 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:131948288-131948310 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:58369500-58369507 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr18:22201794-22201818 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:32332104-32332125 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:128873518-128873532 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:32559175-32559198 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr22:21760406-21760431 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:108044494-108044522 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:16148033-16148056 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:123291374-123291399 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:77025190-77025218 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:123503292-123503313 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:5763637-5763659 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:172631696-172631718 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:27626281-27626287 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:100364133-100364158 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:78853664-78853691 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:67386412-67386436 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:150576107-150576133 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:87340136-87340164 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:122894628-122894648 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:70385379-70385400 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:128098324-128098346 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:18209234-18209256 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:109019884-109019904 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:3782098-3782125 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:27313342-27313365 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:31281146-31281171 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:176526987-176527015 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:134688199-134688225 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr18:59330149-59330173 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:95584049-95584077 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:120855708-120855714 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:120855811-120855831 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr22:21698011-21698031 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:19696143-19696170 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:107201497-107201519 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:31778858-31778883 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:117831791-117831817 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:34907869-34907894 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
JKAMP (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:59495034-59495056 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CDK2AP1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:123261402-123261426 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BAZ2A (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:56595936-56595959 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ASZ1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:117382127-117382150 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AMOTL2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:134356237-134356259 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AKAP9 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:92052898-92052921 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CLIP1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:122271705-122271732 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NDUFC1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:139289987-139290009 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:139289987-139290009 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TCF7L2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:113167206-113167228 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MORF4L2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:103675762-103675784 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SOAT1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:179354646-179354673 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SMEK1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:91458125-91458147 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZC3H12C (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:110166125-110166150 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BTBD11 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:107650859-107650881 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
H2AFV (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:44834357-44834384 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SET (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:128695515-128695541 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CALD1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:134970043-134970070 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FRYL (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:48498044-48498066 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RBMX (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:136869643-136869666 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TPRG1L (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:3629281-3629309 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ERI1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:9032456-9032479 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MIER3 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:56921542-56921554 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MDM2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:68842404-68842427 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
USP10 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:84779262-84779284 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NCKAP1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:183003253-183003279 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BTBD7 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:93240675-93240698 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MATR3 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:139318964-139318987 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
THOC2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:123602193-123602214 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
VPS33A (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:122229796-122229818 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SCAF11 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:45920144-45920165 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PPHLN1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:42398911-42398933 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SLC11A2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:50988172-50988196 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
APLP2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:130143687-130143701 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SYBU (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:109574788-109574811 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MFSD9 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:102715890-102715917 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ACVR2B (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:38484605-38484631 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TMEM66 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:30063729-30063754 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BUB3 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:123162386-123162407 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GLS (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:190935087-190935110 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZFHX3 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:72786188-72786216 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PAPOLA (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:96565179-96565202 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SYNJ1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr21:32630863-32630886 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CPS1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:210595523-210595548 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LPIN1 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:11827266-11827289 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
KIN (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:7755318-7755341 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SDF2 (hsa) 

hsa-miR-105-5p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:28648817-28648840 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0